Ergocalciferol is a form of vitamin D used to treat or prevent vitamin D deficiency, which can cause weak bones and muscles. It helps your body absorb calcium and maintain healthy bones.[2] Calciferol is currently approved and in use across 80 indications[4].[1]
Calciferol is one of 1533 small molecule programs targeting Insulin resistance. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
FDA Application
NDA/BLA/ANDA regulatory filings
Pipeline
Competition
2828 competitors in Breast Cancer
Calciferol
Trodelvy
Avastin
Prolia
Cymbalta
MS Contin
Acupan
Feraheme
Neoadjuvant Treatment
Recombinant Human Endostatin
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Regulatory
Jan 1, 1982
DRISDOL
NDA NDA003444
Sources
Details